knowledge -WSS

knowledge

author：Wikipedia 2025-08-12 09:08:57 - browse：83933

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons.

The medicine, marketed as Lenmeldy, is the first treatment for MLD, which is otherwise fatal. Lenmeldy has to be given before symptoms appear or, in some cases, after the first signs of disease, so it won’t be helpful for many patients living with MLD today. But when given in time, it appears to be near-curative, allowing some children to grow up and attend school with unaffected peers.

Lenmeldy is already marketed in Europe, under the name Libmeldy, and has helped a handful of patients in the U.S. who were treated under compassionate use, as their doctors feared they didn’t have time to wait for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Inaction leaves children at risk from dangerous chemotherapy drug

entertainment

WSS

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Cardiologists urge adding sexual orientation, gender identity to health records

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

1 dead, 9 hurt in July 4th fireworks explosion

Greece's new parliament sworn in following conservative party's election victory

leisure time

knowledge

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

The inclusion problem at the heart of rehabilitation research

What does generative AI mean for health care? We asked experts

Dana Farber says 6 studies to be retracted and 31 corrected

In age of alternative facts, a scholarly course on calling out crap

Noem? Reynolds? A very early look at the Republican 'veepstakes'

Drug repurposing or repositioning? The language matters

Pumping milk in bathrooms at health conferences is common

In Memoriam: Notable people who died in 2023

High breast density mammograms need follow

hotspot

Churchill Downs extends trainer Bob Baffert's ban through 2024

TikTok, Instagram influencers need more rules for drug ads

Pumping milk in bathrooms at health conferences is common

Cardiologists urge adding sexual orientation, gender identity to health records

Dog Aging Project founders on what lies ahead after losing funding

Cardiologists urge adding sexual orientation, gender identity to health records

focus

focus

entertainment

focus